Axcella Health Stock Shares Outstanding
| AXLADelisted Stock | USD 0.20 0.02 11.11% |
Axcella Health fundamentals help investors to digest information that contributes to Axcella Health's financial success or failures. It also enables traders to predict the movement of Axcella Stock. The fundamental analysis module provides a way to measure Axcella Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Axcella Health stock.
Axcella |
Axcella Health Company Shares Outstanding Analysis
Axcella Health's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Axcella Health Shares Outstanding | 2.95 M |
Most of Axcella Health's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Axcella Health is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
CompetitionBased on the latest financial disclosure, Axcella Health has 2.95 M of shares currently outstending. This is 98.37% lower than that of the Biotechnology sector and 97.24% lower than that of the Health Care industry. The shares outstanding for all United States stocks is 99.48% higher than that of the company.
Axcella Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Axcella Health's direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Axcella Health could also be used in its relative valuation, which is a method of valuing Axcella Health by comparing valuation metrics of similar companies.Axcella Health is currently under evaluation in shares outstanding category among its peers.
Axcella Fundamentals
| Return On Equity | -13.7 | |||
| Return On Asset | -0.88 | |||
| Current Valuation | 1.94 M | |||
| Shares Outstanding | 2.95 M | |||
| Shares Owned By Insiders | 15.77 % | |||
| Shares Owned By Institutions | 66.67 % | |||
| Number Of Shares Shorted | 78.18 K | |||
| Price To Earning | (1.10) X | |||
| Price To Book | 8.74 X | |||
| EBITDA | (67.01 M) | |||
| Net Income | (81.19 M) | |||
| Cash And Equivalents | 44.4 M | |||
| Cash Per Share | 0.84 X | |||
| Total Debt | 2.16 M | |||
| Debt To Equity | 3.02 % | |||
| Current Ratio | 2.69 X | |||
| Book Value Per Share | (0.77) X | |||
| Cash Flow From Operations | (69.59 M) | |||
| Short Ratio | 0.75 X | |||
| Earnings Per Share | (18.25) X | |||
| Target Price | 10.62 | |||
| Number Of Employees | 11 | |||
| Beta | 1.01 | |||
| Market Capitalization | 13.5 M | |||
| Total Asset | 18.93 M | |||
| Retained Earnings | (418.43 M) | |||
| Working Capital | 3.88 M | |||
| Current Asset | 61.65 M | |||
| Current Liabilities | 6.16 M | |||
| Z Score | -38.64 | |||
| Net Asset | 18.93 M |
About Axcella Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Axcella Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Axcella Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Axcella Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Consideration for investing in Axcella Stock
If you are still planning to invest in Axcella Health check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Axcella Health's history and understand the potential risks before investing.
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |